Skip to main content
European Commission logo print header

Digital Enterprise Innovations for Bioimaging, Biosensing and Biobanking Industries

Project description

Digital solutions for the healthcare sector

The future of medicine is digital. Called Health Economy 4.0 the Big Data revolution that is currently underway will forever change how healthcare is delivered. This will drive personalised medicine and reconfigure the medical diagnostics value chain. According to the EU-funded DIGI-B-CUBE project, a special focus will be on the biobanking, bioimaging and biosensing industries. The project will identify the cross-sectoral collaborative potential of small and medium-sized enterprises by combining artificial intelligence and cognitive computing digital technologies with the bioimaging-biosensing-biobanking industries. Its goal will be to deliver market-sensitive disruptive technologies and generate innovative solutions that enhance patient-centred diagnostic work-flows. By accelerating personalised medicine, patients will benefit from fast and efficient healthcare systems.

Objective

DIGI-B-CUBE project aims to unlock the cross-sectoral collaborative potential of SMEs by combining Artificial Intelligence (AI), Cognitive Computing Digital Technologies (CCDT) with the Bioimaging-Biosensing-Biobanking (B-CUBE) and realted industries to deliver market sensitive disruptive technologies and generating innovative solutions that enhance patient-centred diagnostic work-flows, delivered through the improved algorithms for Medical Diagnostics’ efficiency and accuracy. DIGI-B-CUBE will study the characteristics in market dynamics & specificities for innovations created by merging AI, CCDT & B-CUBE and realted industries. By providing a framework for a more structured cross-sectoral and cross-border collaboration, that manages all the complex work-flows within the process, DIGI-B-CUBE instantiates the mechanisms to ensure the long-term sustainability of the action through collaborations of the participating clusters with hospitals, academia, industry, investors, business angels, managing authorities of the national innovation agencies and the European Commission support measures (such as EIT, ESIF). The main objective of this project is to provide key digital solutions for the reconfiguration of the Medical Diagnostics and related value chains towards a Health Economy 4.0 with a special focus on Biobanking, Bioimaging and Biosensing and realted industries. Activities financed by the ESIF in the participating regions as part of the Smart Specialisation Strategies will be bundled in cooperation with the responsible managing authorities in addition to the innovation voucher scheme for SMEs. By integrating innovations in IT into Bioimaging, Biosensing and Biobanking and realted industries, this project will accelerate the goal of personalised medicine that can eventually offer patients with fast and efficient diagnosis-treatment-healthcare system.

Call for proposal

H2020-INNOSUP-2018-2020

See other projects for this call

Sub call

H2020-INNOSUP-2018-01-two-stage

æ

Coordinator

OSLO CANCER CLUSTER SA
Net EU contribution
€ 3 565 806,98
Address
Ullernchausseen 64
0379 Oslo
Norway

See on map

Region
Norge Oslo og Viken Oslo
Activity type
Other
Links
Other funding
€ 0,00

Participants (8)